Skip to main content

At your home, office, or destination—trained nurses can administer your injection,* at no charge to you

As a patient receiving Sandostatin® LAR Depot (octreotide acetate) for injectable suspension therapy, you know how important it is to keep your regularly scheduled appointments and get your injections exactly as prescribed. That’s why the Mobile Administration Program (MAP) was developed—to make coordinating your treatment a little easier.

If your doctor recommends you as an appropriate patient to participate in the program and you’re eligible, you’ll be able to receive your injections at home, at work, or while you’re traveling, administered by a MAP nurse who is trained in the mixing and administration of Sandostatin LAR Depot. To take advantage of this convenient way to receive your injections:

  • Find out from your doctor if you’re a candidate for MAP and check if you’re eligible

  • Work with your doctor to complete the enrollment form

* Limitations apply. Program is available only for patients with commercial insurance. Program is not available for patients insured by Medicare, Medicaid, or any other federal or state program. Program is not available for residents of Massachusetts, Michigan, Minnesota, or Rhode Island.

Important things to know about MAP

  • MAP does not replace your doctor’s care; you should still go to your regular doctor for checkups. MAP allows you to receive your injections at a time and location convenient for you

  • If you are new to Sandostatin LAR Depot, your first dose must be received in your doctor’s office


MAP Eligibility

The MAP is available to all eligible patients for whom Sandostatin LAR Depot has been prescribed for a US Food and Drug Administration–approved indication.

  • Residents of all states except Massachusetts, Michigan, Minnesota, and Rhode Island can participate

  • MAP is available to eligible patients covered by most commercial plans (eg, HMO, PPO) generally available to patients with commercial insurance

  • The program is not available for patients insured by Medicare, Medicaid, or other federal or state programs

  • Visit Patient Assistance Now Oncology (PANO) to get help accessing your medicine and to download a service request form


For more information on financial help, visit Patient Assistance Now Oncology.
 

What MAP Offers
  • Receive Sandostatin injections at convenient locations. When you’re dealing with acromegaly or carcinoid syndrome, this program offers a convenient administration option

  • Your Sandostatin, your schedule. Nurses are available outside traditional office hours, including weekends and evenings, or even when you are traveling out of town

  • Receive Sandostatin injections from a trained health care professional. The MAP nurse will let your doctor know you have received your medicine (or injection). You will receive your Sandostatin injections at a location convenient to you


How MAP Works

Just 4 simple steps to receive your injections at home:

1

Your doctor recommends you for the program and submits your enrollment form.

2

Your eligibility is verified.

3

You will receive a call to schedule your next injection at your convenience.

4

MAP nurse who is specially trained in the mixing and administration of Sandostatin LAR Depot meets you at a convenient time and place and gives the injection, makes the next appointment, follows up with a reminder, and notifies your doctor that you received your injection.

Frequently Asked Questions

MAP for Eligible Patients

The Mobile Administration Program (MAP) is generally available to commercially insured patients for whom Sandostatin LAR Depot has been prescribed. The program is not available to patients insured by Medicare, Medicaid, or other federal or state programs. The program is not available for residents of Massachusetts, Michigan, Minnesota, or Rhode Island.

Important Safety Information

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications...

Approved Uses

Sandostatin® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin® ...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES